Is increased cost an acceptable justification for not including women, minorities and subpopulations in clinical research studies?
NO. The legislation states that the cost associated with increasing the diversity of a clinical research study population composition to include the appropriate representation of men, women, and members of minority groups and their subpopulations is not an acceptable justification for excluding any group.
Related Questions
- How will conformance to the policy for inclusion of women and minorities in clinical research affect funding of grants and cooperative agreements?
- How will conformance to the policy for inclusion of women and minorities in clinical research affect funding of contracts?
- Is increased cost an acceptable justification for not including women, minorities, and minority subpopulations?
